Ergotism of the central nervous system. Report of two maternal deaths associated with cerebral vasospasm due to ergot-derived drugs in Antioquia, Colombia, and review of the literature
DOI:
https://doi.org/10.18597/rcog.771Keywords:
Maternal mortality, ergotism, ergot-derived alkaloids, cerebral vasospasm, postpartumAbstract
Objective: To report two cases of maternal death associated with ergot-derived drugs (acute sever ergotism), and to conduct and review of the literature on central nervous system adverse events during the postpartum period in women exposed to these medications.
Materials and methods: Two cases of maternal death during the postpartum period. The first was associated with the use of bromocriptine for breast milk suppression, and the second was associated with the use of methylergometrine for the control of bleeding after Cesarean section. The patients received care at Level III institutions in the city of Medellín, Colombia. A review of the literature was conducted in the Medline database through Pubmed. The terms used for the search were: ergot derivatives, bromocriptine, postpartum cerebral angiitis, ergotism, postpartum cerebral vascular disease. The search was conducted without a time limitation and included, case reports, case series reports, and reviews. The search also included safety reports or alerts from regulatory agencies such as the FDA, the European Medicines Agency (EMA), and Invima. Articles in English, French and Spanish were reviewed.
Results: Overall, 16 publications that met the search criteria were included, and 33 cases were identified. Two of the cases were fatal, one associated with the use of intravenous methylergonovine for delivery and the second one was associated with the use of oral ergometrine to induce abortion at 20 weeks of gestation. Neuroimaging studies show, predominantly, ischemic findings (suggestive of cerebral vasospasm). In three cases, intracranial haemorrhage was reported, and one of the three cases was fatal. The most frequent presenting symptoms were intense headache, followed by seizures. It was possible to identify a history of hypertension and/or preeclampsia only in nine cases, and a history of migraine in four. The vast majority of patients were otherwise healthy. In all the cases, the indication for using bromocriptine was breast milk suppression. In the three reported cases in which methylergonovine was used, the indication was to assist delivery. No reports of serious adverse
events associated with these drugs were found in the Colombian pharmacovigilance system.
Conclusion: Ergotism of the central nervous system due to the use of drugs such as bromocriptine and methylergonovine must be recognised during the postpartum period because it is life-threatening. It is important to create a culture of reporting of serious adverse events associated with these medications in our country.
Author Biographies
Jesús A. Velásquez-Penagos
Jorge Mario Gómez-Jiménez
Bernardo Agudelo-Jaramillo
References
Eadie MJ. Convulsive ergotism: epidemics of the serotonin syndrome? Lancet Neurol. 2003 [visitado 2013 Feb 21];2(7):429-34. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/12849122
Williams TL, Lukovits TG, Harris BT, Harker Rhodes C. A fatal case of postpartum cerebral angiopathy with literature review. Arch Gynecol Obstet . 2007 [visitado 2013 Feb 21];275:67-77. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/16832640
De Costa C. St Anthony’s fire and living ligatures: a short history of ergometrine. Lancet. 2002 [visitado 2013 Feb 1];359(9319):1768-70. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/12049883
Schiff PL. Ergot and its alkaloids. Am J Pharm Educ. 2006 [visitado 2013 Apr 9];70(5):98. Disponible en: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1637017&tool=pmcentrez&rendertype=abstract
De Groot AN, van Dongen PW, Vree TB, Hekster YA, van Roosmalen J. Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology. Drugs. 1998 [visitado 2013 Feb 21];56:523-35. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/9806101
Belfort MA, Saade GR, Grunewald C, Dildy GA, Varner MA, Nisell H. Effects of blood pressure on orbital and middle cerebral artery resistances in healthy pregnant women and women with preeclampsia. Am J Obstet Gynecol. 1999;180:601-7.
Bernard N, Jantzem H, Becker M, Pecriaux C, Bénard-Laribière A, Montastruc JL, et al. Severe adverse effects of bromocriptine in lactation inhibition: A pharmacovigilance survey. BJOG. 2015;122:1244-51.
Bridger MG, Rodan KS. Ergot poisoning causing death in pregnancy. Br Med J. 1958 [visitado 2013 Feb 21];1(5061):28.Disponible en: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2026632&tool=pmcentrez&rendertype=abstract
Abouleish E. Postpartum hypertension and convulsion after oxytocic drugs. Anesth Analg. 1976 [visitado 2013 Feb 21];55(6):813-5. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/1033698
Kulig K, Moore LL, Kirk M, Smith D, Stallworth J, Rumack B. Bromocriptine-associated headache: possible life-threatening sympathomimetic interaction. Obstet Gynecol. 1991;78(5 Pt 2):941-3. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/1923236
Barinagarrementeria F, Cantú C, Balderrama J. Postpartum cerebral angiopathy with cerebral infarction due to ergonovine use. Stroke. 1992 [visitado 2013 Feb 21];23:1364-6. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/1519295
Janssens E, Hommel M, Mounier-Vehier F, Leclerc X, Guerin du Masgenet B, Leys D. Postpartum cerebral angiopathy possibly due to bromocriptine therapy. Stroke. 1995 [visitado 2013 Feb 21];26:128-30. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/7839382
Lucas C, Deplanque D, Salhi A, Hachulla E, Doumith S. [Benign angiopathy of the puerperium: a clinicoradiological case associated with ingestion of bromocriptine]. Rev Med Interne. 1996 [visitado 2013 Feb 21];17:839-41. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/8976978
Comabella M, Alvarez-Sabin J, Rovira A, Codina A. Bromocriptine and postpartum cerebral angiopathy: a causal relationship? Neurology. 1996 [visitado 2013 Feb 21];46:1754-6. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/8649587
Chartier JP, Bousigue JY, Teisseyre A, Morel C, Delpuech-Formosa F. [Postpartum cerebral angiopathy of iatrogenic origin]. Rev Neurol (Paris). 1997 [visitado 2013 Feb 21];153:212-4. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/9296138
Granier I, Garcia E, Geissler A, Boespflug MD, Durand-Gasselin J. Postpartum cerebral angiopathy associated with the administration of sumatriptan and dihydroergotamine--a case report. Intensive Care Med. 1999 [visitado 2013 Feb 21];25:532-4. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/10401952
Crippa G, Sverzellati E, Pancotti D, Carrara GC. Severe postpartum hypertension and reversible cerebral angiopathy associated with ergot derivative (methergoline) administration. Ann Ital Med Int. 2000 [visitado 2013 Apr 9];15:303-5. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/11202634
Kirsch C, Iffy L, Zito GE, McArdle JJ. The role of hypertension in bromocriptine-related puerperal intracranial hemorrhage. Neuroradiology. 2001 [visitado 2013 Feb 21];43:302-4. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/11338413
Burckard E, Patrigeon RG, Felten D, Combourieu E, Escarment J. [Convulsions due to a postpartum cerebral angiopathy associated with the administration of bromocriptine]. Ann Fr Anesth Reanim. 2003 [visitado 2013 Feb 21];22:46-9. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/12738020
Barroso B, Bigou P, Martin K, Lippa A, Chabouni L, Dakar A, et al. [Reversible postpartum cerebral angiopathy associated with bromocriptine therapy]. Rev Neurol (Paris). 2004 [visitado 2013 Feb 21];160:1191-3. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/15602366
Ishibashi T, Ishibashi S, Uchida T, Nakazawa K, Makita K. Reversible cerebral vasoconstriction syndrome with limb myoclonus following intravenous administration of methylergometrine. J Anesth. 2011 [visitado 2013 Feb 21];25:405-8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21431624
Farissier F, Reynaud A, Varvat J, Coudrot M, Garnier P, Tardy B. [Postpartum reversible cerebral angiopathy: an unusual cause of headache]. Ann Fr Anesth Reanim. 2011 [visitado 2013 Feb 21];30:61-3. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21185686
Gittelman DK. Bromocriptine associated with postpartum hypertension, seizures, and pituitary hemorrhage. Gen Hosp Psychiatry. 1991;13:278-80.
Katz M, Kroll D, Pak I, Osimoni A, Hirsch M. Puerperal hypertension, stroke, and seizures after suppression of lactation with bromocriptine. Obstet Gynecol. 1985;66(6):822-4. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/3840873
De Jong-van den Berg L, Mintzes B. Bromocriptine and lactation suppression: Are the risks acceptable? Pharm World Sci. 1995;17:93-5.
Iffy L, Lindenthal JJ, McArdle JJ, McNamara RE, Szodi Z, Ganesh V. Ergotism: a possible etiology for puerperal psychosis. Obstet Gynecol. 1989 [visitado 2013 Feb 21];73(3 Pt 2):475-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/2915878
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Revista Colombiana de Obstetricia y Ginecología
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
